These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31037153)
1. Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis. von Knethen A; Schäfer A; Kuchler L; Knape T; Christen U; Hintermann E; Fißlthaler B; Schröder K; Brandes RP; Genz B; Abshagen K; Pützer BM; Sha LK; Weigert A; Syed SN; Schulz M; Shah AM; Ernst A; Putyrski M; Finkelmeier F; Pesic M; Greten F; Hogardt M; Kempf VAJ; Gunne S; Parnham MJ; Brüne B Theranostics; 2019; 9(7):2003-2016. PubMed ID: 31037153 [TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation. Li W; Tu J; Liu X; Yang W Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912 [TBL] [Abstract][Full Text] [Related]
3. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis. Hu YM; Hsiung YC; Pai MH; Yeh SL JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555 [TBL] [Abstract][Full Text] [Related]
4. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis]. Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331 [TBL] [Abstract][Full Text] [Related]
5. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction. Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333 [TBL] [Abstract][Full Text] [Related]
6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Waeckerle-Men Y; Starke A; Wüthrich RP Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272 [TBL] [Abstract][Full Text] [Related]
7. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Zhang Y; Zhou Y; Lou J; Li J; Bo L; Zhu K; Wan X; Deng X; Cai Z Crit Care; 2010; 14(6):R220. PubMed ID: 21118528 [TBL] [Abstract][Full Text] [Related]
8. MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice. Zhen J; Chen W Biomed Pharmacother; 2018 Jan; 97():1479-1485. PubMed ID: 29793310 [TBL] [Abstract][Full Text] [Related]
9. Activation of the peroxisome proliferator-activated receptor γ counteracts sepsis-induced T cell cytotoxicity toward alloantigenic target cells. von Knethen A; Sha LK; Knape T; Kuchler L; Giegerich AK; Schulz M; Hauser IA; Brüne B J Mol Med (Berl); 2015 Jun; 93(6):633-44. PubMed ID: 25559266 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice. Zhao ZZ; Wang XL; Xie J; Chen LP; Li Q; Wang XX; Wang JF; Deng XM Med Sci Monit; 2021 Jan; 27():e926820. PubMed ID: 33421049 [TBL] [Abstract][Full Text] [Related]
11. Novel Role for PD-1:PD-L1 as Mediator of Pulmonary Vascular Endothelial Cell Functions in Pathogenesis of Indirect ARDS in Mice. Lomas-Neira J; Monaghan SF; Huang X; Fallon EA; Chung CS; Ayala A Front Immunol; 2018; 9():3030. PubMed ID: 30619369 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Zhu W; Bao R; Fan X; Tao T; Zhu J; Wang J; Li J; Bo L; Deng X Mediators Inflamm; 2013; 2013():361501. PubMed ID: 24324295 [TBL] [Abstract][Full Text] [Related]
13. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis. Wang JF; Wang YP; Xie J; Zhao ZZ; Gupta S; Guo Y; Jia SH; Parodo J; Marshall JC; Deng XM Blood; 2021 Sep; 138(9):806-810. PubMed ID: 34473230 [TBL] [Abstract][Full Text] [Related]
14. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
15. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression. Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183 [TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of Donor Dendritic Cell PD-L1 Expression Reduced Recipient Lymphocyte Activation and Proliferation In Vitro. Li T; Ma R; Zhu JY Transplant Proc; 2021 Mar; 53(2):716-723. PubMed ID: 33551184 [TBL] [Abstract][Full Text] [Related]
17. Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis. Zhou J; Peng H; Li K; Qu K; Wang B; Wu Y; Ye L; Dong Z; Wei H; Sun R; Tian Z Immunity; 2019 Feb; 50(2):403-417.e4. PubMed ID: 30709740 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis. Higuchi S; Wu R; Zhou M; Ravikumar TS; Wang P J Surg Res; 2007 Jan; 137(1):46-52. PubMed ID: 17101152 [TBL] [Abstract][Full Text] [Related]
19. Reactive glia promote development of CD103 Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245 [TBL] [Abstract][Full Text] [Related]
20. Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis. Avendaño-Ortiz J; Maroun-Eid C; Martín-Quirós A; Lozano-Rodríguez R; Llanos-González E; Toledano V; Gómez-Campelo P; Montalbán-Hernández K; Carballo-Cardona C; Aguirre LA; López-Collazo E Front Immunol; 2018; 9():2008. PubMed ID: 30233593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]